C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604 · see citing works

C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?

Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · see citing works

Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome

Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease

Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · see citing works

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,241 · see citing works

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098 · see citing works

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes

Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057 · see citing works

Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,001 · see citing works

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 882 · see citing works

C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

Mendall, M. A., Patel, P., Ballam, L., Strachan, D. P., & Northfield, T. C. (1996) · BMJ · doi:10.1136/bmj.312.7038.1061 · Cited by 847 · see citing works

C-Reactive Protein as a Cardiovascular Risk Factor

Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833 · see citing works

Hypertension and the Pathogenesis of Atherosclerosis

Alexander, R. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.155 · Cited by 785 · see citing works

Insulin Inhibits Intranuclear Nuclear Factor B and Stimulates I B in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect?

Dandona, P., Aljada, A., Mohanty, P., Ghanim, H., Hamouda, W., Assian, E., & Ahmad, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7623 · Cited by 695 · see citing works

C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells

Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 641 · see citing works

Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells

Marx, N., Schönbeck, U., Lazar, M. A., Libby, P., & Plutzky, J. (1998) · Circulation Research · doi:10.1161/01.res.83.11.1097 · Cited by 587 · see citing works

Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor

Stuehlinger, M. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · see citing works

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2167 · Cited by 539 · see citing works

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

Lang, C. H., Dobrescu, C., & Bagby, G. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727716 · Cited by 535 · see citing works

Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes

Lebovitz, H. E., Dole, J., Patwardhan, R., Rappaport, E. B., & Freed, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7157 · Cited by 518 · see citing works

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Han, T. S., Sattar, N. A., Williams, K., González‐Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 514 · see citing works

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

Arner, P. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00024-9 · Cited by 423 · see citing works

Inflammatory Cytokines Impair Endothelium-Dependent Dilatation in Human Veins In Vivo

Bhagat, K., & Vallance, P. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.3042 · Cited by 409 · see citing works

PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer

Murphy, G. J., & Holder, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01559-5 · Cited by 386 · see citing works

Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S. M., Wakino, S., Noh, G. J., Palinski, W., Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.365 · Cited by 384 · see citing works

A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes

Sutton, M. S. J., Rendell, M., Dandona, P., Dole, J., Murphy, K., Patwardhan, R., Patel, J., & Freed, M. I. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2058 · Cited by 254 · see citing works

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

Cleland, S. J., Sattar, N. A., Petrie, J. R., Forouhi, N. G., Elliott, H. L., & Connell, J. (2000) · Clinical Science · doi:10.1042/cs0980531 · Cited by 250 · see citing works

Induction of T-cell activation by oxidized low density lipoprotein.

Frostegård, J., Wu, R., Giscombe, R., Holm, G., Lefvert, A., & Nilsson, J. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.4.461 · Cited by 243 · see citing works

Rosiglitazone reduces urinary albumin excretion in type II diabetes

Bakris, G. L., Viberti, G. C., Weston, W. M., Heise, M. A., Porter, L. E., & Freed, M. I. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001444 · Cited by 240 · see citing works

Suppression of Nuclear Factor-κB and Stimulation of Inhibitor κB by Troglitazone: Evidence for an Anti-inflammatory Effect and a Potential Antiatherosclerotic Effect in the Obese

Ghanim, H., Garg, R., Aljada, A., Mohanty, P., Kumbkarni, Y., Assian, E., Hamouda, W., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7309 · Cited by 218 · see citing works

Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients

Raji, A., Seely, E. W., Bekins, S. A., Williams, G. H., & Simonson, D. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.172 · Cited by 215 · see citing works

Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

Chu, N. V., Kong, A. P. S., Kim, D. D. H., Armstrong, D. A., Baxi, S. C., Deutsch, R., Caulfield, M. P., Mudaliar, S. R. D., Reitz, R. E., Henry, R. R., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.542 · Cited by 195 · see citing works

Tumor Necrosis Factor Stimulates Hepatic Lipid Synthesis and Secretion*

FEINGOLD, K. R., Serio, M., Adi, S., MOSER, A. H., & Grünfeld, C. (1989) · Endocrinology · doi:10.1210/endo-124-5-2336 · Cited by 183 · see citing works

Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha.

Youd, J. M., Rattigan, S., & Clark, M. G. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1904 · Cited by 176 · see citing works

Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells

Ganapathi, M. K., Rzewnicki, D., Samols, D. R., Jiang, S. L., & Kushner, I. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1261 · Cited by 171 · see citing works

Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden

Brevetti, G., Silvestro, A., Giacomo, S. D., Bucur, R., Donato, A. D., Schiano, V., & Scopacasa, F. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00124-1 · Cited by 165 · see citing works

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

Chilcott, J. B., Tappenden, P., Jones, M. L., & Wight, J. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80078-8 · Cited by 151 · see citing works

Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes

Wigmore, S. J., Fearon, K. C. H., Maingay, J. P., Lai, P. B. S., & Ross, J. A. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e720 · Cited by 150 · see citing works

Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells

Stopeck, A., NICHOLSON, A. C., Mancini, F. P., & Hajjar, D. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85360-7 · Cited by 149 · see citing works

Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients

Nakamura, T., Ushiyama, C., Shimada, N., Hayashi, K., Ebihara, I., & Koide, H. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00124-0 · Cited by 145 · see citing works

Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone

Ishibashi, M., Egashira, K., Hiasa, K., Inoue, S., Ni, W., Zhao, Q. D., Usui, M., Kitamoto, S., Ichiki, T., & Takeshita, A. (2002) · Hypertension · doi:10.1161/01.hyp.0000036396.64769.c2 · Cited by 141 · see citing works

Troglitazone Reduces Reactive Oxygen Species Generation by Leukocytes and Lipid Peroxidation and Improves Flow-Mediated Vasodilatation in Obese Subjects

Garg, R., Kumbkarni, Y., Aljada, A., Mohanty, P., Ghanim, H., Hamouda, W., & Dandona, P. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.430 · Cited by 140 · see citing works

Nuclear Factor-κB Suppressive and Inhibitor-κB Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?1

Aljada, A., Garg, R., Ghanim, H., Mohanty, P., Hamouda, W., Assian, E., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7564 · Cited by 133 · see citing works

Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γ

Takata, Y., Kitami, Y., Yang, Z., Nakamura, M., Okura, T., & Hiwada, K. (2002) · Circulation Research · doi:10.1161/01.res.0000031271.20771.4f · Cited by 130 · see citing works

Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled Study

Füllert, S., Schneider, F., Haak, E., Rau, H., Badenhoop, K. W. J., Lübben, G., Usadel, K.-H., & Konrad, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020963 · Cited by 122 · see citing works

Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

N., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116 · see citing works

Physiological Increments in Plasma Insulin Concentrations Have Selective and Different Effects on Synthesis of Hepatic Proteins in Normal Humans

Feo, P. D., Volpi, E., Lucidi, P., Cruciani, G., Reboldi, G., Siepi, D., Mannarino, E., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1993) · Diabetes · doi:10.2337/diab.42.7.995 · Cited by 111 · see citing works

C-reactive protein increases production of IL-1α, IL-1β, and TNF-α, and expression of mRNA by human alveolar macrophages

Rochemonteix, B. G.-D., Wiktorowicz, K., Kushner, I., & Dayer, J. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.53.4.439 · Cited by 109 · see citing works

Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles

Lupattelli, G., Lombardini, R., Schillaci, G., Ciuffetti, G., Marchesi, S., Siepi, D., & Mannarino, E. (2000) · American Heart Journal · doi:10.1067/mhj.2000.108508 · Cited by 108 · see citing works

Endothelial Dysfunction in Essential Hypertension

Panza, J. A. (1997) · Clinical Cardiology · doi:10.1002/j.1932-8737.1997.tb00009.x · Cited by 103 · see citing works

TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis

Bulló, M., García‐Lorda, P., Peinado‐Onsurbe, J., Hernández, M., Castillo, D. D., Argilés, J. M. A., & Salas‐Salvadó, J. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801977 · Cited by 101 · see citing works

Nitric Oxide Synthase in Atherosclerosis and Vascular Injury

Channon, K. M., Qian, H., & George, S. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1873 · Cited by 99 · see citing works

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes

Ebeling, P. R., Teppo, A.-M., Koistinen, H. A., Viikari, J. S. A., R�nnemaa, T., Niss�n, M., Bergkulla, S., Salmela, P. I., Saltevo, J. T., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051315 · Cited by 96 · see citing works

Suppression of Nuclear Factor- B and Stimulation of Inhibitor B by Troglitazone: Evidence for an Anti-inflammatory Effect and a Potential Antiatherosclerotic Effect in the Obese

Ghanim, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1306 · Cited by 93 · see citing works

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects

Yudkin, J. S., Panahloo, A., Stehouwer, C. D. A., EMEIS, J. J., Bulmer, K., Mohamed‐Ali, V., & Denver, A. E. (2000) · Diabetologia · doi:10.1007/s001250051500 · Cited by 88 · see citing works

Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets

Plutzky, J., Viberti, G. C., & Haffner, S. M. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00202-7 · Cited by 81 · see citing works

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

Shinozaki, K., Hirayama, A., Nishio, Y., Yoshida, Y., Ohtani, T., Okamura, T., Masada, M., Kikkawa, R., Kodama, K., & Kashiwagi, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01659-x · Cited by 78 · see citing works

Determinants of C-reactive protein concentration in blood.

de Maat, M. P., & Kluft, C. (2001) · PubMed · Cited by 66 · see citing works

Rapid automated enzyme immunoassay of serum amyloid A

Wilkins, J. A., Gallimore, J. R., Tennent, G. A., Hawkins, P. N., Limburg, P. C., van Rijswijk, M. H., Moore, E. G., & Pepys, M. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.7.1284 · Cited by 65 · see citing works

Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?

Aljada, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3250 · Cited by 64 · see citing works

Variability in the measurement of intracoronary ultrasound images: implicatioNs for the identification of atherosclerotic plaque regression

Foster, G. P., Mittleman, M., Koch, M., Abela, G., & Zarich, S. W. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200105 · Cited by 63 · see citing works

Plaque Disruption and Thrombosis

Shah, P. K. (2000) · Cardiology in Review · doi:10.1097/00045415-200008010-00007 · Cited by 61 · see citing works

Peroxisome proliferator-activated receptors in endothelial cell biology

Plutzky, J. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00006 · Cited by 58 · see citing works

Determinants of C-reactive protein concentration in blood

de Maat, M., & Kluft, C. (2001) · BMC News and views · doi:10.1186/2048-4623-1-s2-002 · Cited by 37 · see citing works

Modulation of vascular inflammation by PPARs

Tham, D. M., Wang, Y., & Rutledge, J. C. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.2.740244 · Cited by 36 · see citing works

Modulation of Early Immune Responses and Suppression of Trypanosoma brucei brucei Infections by Surgical Denervation of the Spleen

Liu, Y., Mustafa, M., Li, H., Nuortio, L., Mustafa, A., & Bakhiet, M. (2000) · NeuroImmunoModulation · doi:10.1159/000026450 · Cited by 33 · see citing works

Insulin resistance affects endothelium-dependent acetylcholine-induced coronary artery response

Inoue, T. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1872 · Cited by 32 · see citing works

Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents

Dandona, P., & Aljada, A. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00259-3 · Cited by 28 · see citing works

Troglitazone Reduces the Expression of PPARγ While Stimulating That of PPARα in Mononuclear Cells in Obese Subjects1

Aljada, A., Ghanim, H., Friedman, J., Garg, R., Mohanty, P., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7624 · Cited by 22 · see citing works

Global public goods: international cooperation in the 21st century edited by Inge Kaul, Isabelle Grunberg and Marc Stern Oxford University Press, 1999, published for UNDP

Collins, P. (2001) · Public Administration and Development · doi:10.1002/pad.133 · Cited by 11 · see citing works

Troglitazone Reduces the Expression of PPAR While Stimulating That of PPAR in Mononuclear Cells in Obese Subjects

Aljada, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3130 · Cited by 8 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

The metabolic syndrome

Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,283 · see citing works

2007 Guidelines for the Management of Arterial Hypertension

Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,818 · see citing works

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655 · see citing works

The metabolic syndrome

Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,566 · see citing works

2007 Guidelines for the management of arterial hypertension

Mancia, G., Backer, G. D., Dominiczak, A. F., Cifkova, R., Fagard, R., Germano, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384 · see citing works

Periodontitis and diabetes: a two-way relationship

Preshaw, P. M., Alba, A. L., Herrera, D., Jepsen, S. V., Konstantinidis, A. O., Makrilakis, K., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2342-y · Cited by 1,953 · see citing works

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Timon, I. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 982 · see citing works

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

Baker, A. R., da Silva, N. F., Quinn, D. W., Harte, A. L., Pagano, D., Bonser, R. S., Kumar, S., & McTernan, P. G. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-1 · Cited by 642 · see citing works

Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption

Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine · doi:10.1038/nm1278 · Cited by 608 · see citing works

Effect of Periodontal Treatment on Glycemic Control of Diabetic Patients

Teeuw, W. J., Gerdes, V. E. A., & Loos, B. G. (2010) · Diabetes Care · doi:10.2337/dc09-1378 · Cited by 526 · see citing works

Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism

Sharma, A. M., & Staels, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1268 · Cited by 477 · see citing works

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

Stettler, C., Allemann, S., Jüni, P., Cull, C. A., Holman, R. R., Egger, M., Krähenbühl, S., & Diem, P. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.015 · Cited by 468 · see citing works

Diagnosis and management of the metabolic syndrome

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000200416.65370.a0 · Cited by 434 · see citing works

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

Strachan, M. W. J., Reynolds, R. M., Marioni, R. E., & Price, J. F. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.228 · Cited by 402 · see citing works

2007 ESH‐ESC Guidelines for the management of arterial hypertension

Mansia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Blood Pressure · doi:10.1080/08037050701461084 · Cited by 358 · see citing works

Markers of Inflammation

Germolec, D. R., Shipkowski, K. A., Frawley, R. P., & Evans, E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8549-4_5 · Cited by 358 · see citing works

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 294 · see citing works

Insulin Resistance as the Underlying Cause for the Metabolic Syndrome

Lann, D. E., & LeRoith, D. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.012 · Cited by 250 · see citing works

High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus

Pfützner, A., & Forst, T. M. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.28 · Cited by 218 · see citing works

Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy

Watson, N., Ding, B., Zhu, X., & Frisina, R. D. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.002 · Cited by 213 · see citing works

Diabetes Mellitus and Dementia

Ninomiya, T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0487-z · Cited by 211 · see citing works

Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease

Rana, J. S., Nieuwdorp, M., Jukema, J. W., & Kastelein, J. J. P. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00594.x · Cited by 209 · see citing works

Markers of Inflammation

Germolec, D. R., Frawley, R. P., & Evans, E. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-401-2_5 · Cited by 194 · see citing works

Age Related Shift in Visceral Fat.

Hunter, G. R., Gower, B. A., & Kane, B. (2010) · PubMed · Cited by 160 · see citing works

Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Kalofoutis, C., Piperi, C., Kalofoutis, A., Harris, F., Phoenix, D. A., & Singh, J. (2007) · PubMed Central · Cited by 149 · see citing works

Periodontitis and type II diabetes: a two-way relationship.

Chee, B., Park, B., & Bartold, P. (2013) · International Journal of Evidence-Based Healthcare · doi:10.1111/1744-1609.12038 · Cited by 148 · see citing works

Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys

Yaribeygi, H., Katsiki, N., Butler, A. E., & Sahebkar, A. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.08.005 · Cited by 141 · see citing works

Endothelial Dysfunction in Diabetes: Pathogenesis, Significance, and Treatment

Hamilton, S. J., & Watts, G. F. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.133 · Cited by 139 · see citing works

C-reactive Protein, Body Mass Index, and Diabetic Retinopathy

Lim, L. S., Tai, E. S., Mitchell, P. L. R., Wang, J. J., Tay, W. T., Lamoureux, E. L., & Wong, T. Y. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4939 · Cited by 129 · see citing works

Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease

Katagiri, S., Nitta, H., Nagasawa, T., Uchimura, I., Izumiyama, H., Inagaki, K., Kikuchi, T., Noguchi, T., Kanazawa, M., Matsuo, A., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.016 · Cited by 111 · see citing works

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel

Shepherd, J., Betteridge, J. D., Gaal, L. V., & Panel, O. B. O. A. E. C. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x43677 · Cited by 100 · see citing works

Consequences of Weight Cycling: An Increase in Disease Risk?

Strohacker, K. A., Carpenter, K. C., & McFarlin, B. K. (2009) · International journal of exercise science · doi:10.70252/asaq8961 · Cited by 96 · see citing works

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus

Hamilton, S. J., Chew, G. T., & Watts, G. F. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.026 · Cited by 94 · see citing works

Influence of obesity physical inactivity and weight cycling on chronic inflammation

McFarlin, B. K. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e70 · Cited by 93 · see citing works

Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus

Woodman, R. J., Chew, G. T., & Watts, G. F. (2005) · Drugs · doi:10.2165/00003495-200565010-00003 · Cited by 83 · see citing works

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

Gerrits, C. M., Bhattacharya, M., Manthena, S. R., Baran, R. W., Perez, A., & Kupfer, S. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1470 · Cited by 82 · see citing works

Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007

(ESH), G. D. T. P. E. T. D. L. H. A. D. L. S. E. D. H., & de Cardiología, D. L. S. E. (2007) · Revista Española de Cardiología · doi:10.1157/13109650 · Cited by 79 · see citing works

Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites

Rhea, E. M., Banks, W. A., & Raber, J. (2022) · Biomedicines · doi:10.3390/biomedicines10071582 · Cited by 76 · see citing works

Treating the metabolic syndrome

Bianchi, C., Penno, G., Romero, F., Prato, S. D., & Miccoli, R. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.3.491 · Cited by 74 · see citing works

Type 2 diabetes mellitus as inflammatory disease

Zozulińska‐Ziółkiewicz, D., & Wierusz‐Wysocka, B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.007 · Cited by 70 · see citing works

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride

Pfützner, A., Schöndorf, T., Seidel, D., Winkler, K., Matthaei, S., Hamann, A., & Forst, T. M. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.021 · Cited by 70 · see citing works

Insulin Sensitivity in African‐American and White Women: Association With Inflammation

Hyatt, T. C., Phadke, R. P., Hunter, G. R., Bush, N. C., Muñoz, A. J., & Gower, B. A. (2009) · Obesity · doi:10.1038/oby.2008.549 · Cited by 67 · see citing works

Effects of low- and high-glycemic index/glycemic load diets on coronary heart disease risk factors in overweight/obese men

Shikany, J. M., Phadke, R. P., Redden, D. T., & Gower, B. A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.006 · Cited by 67 · see citing works

Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health

Zulet, M. A., Marti, A., Parra, M. D., & Martínez, J. A. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168454 · Cited by 62 · see citing works

Metabolic complications of obesity: inflated or inflamed?

Chandalia, M., & Abate, N. I. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.004 · Cited by 58 · see citing works

Epidemiological Evidence of the Relationship Between Diabetes and Dementia

Ninomiya, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_2 · Cited by 57 · see citing works

Impact of Metabolic Syndrome on the Long-Term Survival of Patients With Acute Myocardial Infarction Potential Association With C-Reactive Protein

Takeno, M., Yasuda, S., Otsuka, Y., Morii, I., Kawamura, A., Yano, K., & Miyazaki, S. (2008) · Circulation Journal · doi:10.1253/circj.72.415 · Cited by 56 · see citing works

Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness

Jernås, M., Olsson, B., Sjöholm, K., Sjögren, A., Rudemo, M., Nellgård, B., Carlsson, L. M. S., & Sjöström, C. D. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.012 · Cited by 55 · see citing works

Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus.

Shahen, V., Gerbaix, M., Koeppenkastrop, S., Lim, S., McFarlane, K., Nguyen, A., Peng, X.-Y., Weiss, N. B., & Brennan-Speranza, T. (2020) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2020.04.001 · Cited by 51 · see citing works

Is Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) a Risk Factor for Cardiovascular Events?

Calverley, P. M. A., & Scott, S. (2006) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550600977544 · Cited by 50 · see citing works

Management of the metabolic syndrome.

Hafidh, S., Senkottaiyan, N., Alpert, M., & Villarreal, D. (2005) · American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00013 · Cited by 8 · see citing works

Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA Study)

Betteridge, D. J., Gibson, M., & Sager, P. T. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.044 · Cited by 46 · see citing works

Multi-Omics Insights into Functional Alterations of the Liver in Insulin-Deficient Diabetes Mellitus

Backman, M., Flenkenthaler, F., Blutke, A., Dahlhoff, M., Ländström, E., Renner, S., Philippou‐Massier, J., Krebs, S., Rathkolb, B., Prehn, C. P., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.011 · Cited by 40 · see citing works

Celastrol: A Promising Agent Fighting against Cardiovascular Diseases

Li, Z., Zhang, J., Duan, X., Zhao, G., & Zhang, M. (2022) · Antioxidants · doi:10.3390/antiox11081597 · Cited by 40 · see citing works

C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians

Wang, Z., & Hoy, W. E. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.018 · Cited by 38 · see citing works

2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European

Mancia, G., Dominiczak, A. F., Fagard, R. H., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Schmieder, R. E., Vahanian, A. S., Camm, A. J., Dean, V., et al. (2007) · Cited by 38 · see citing works

Biological Underpinnings of Health Alterations in Women With PTSD: A Sex Disparity

Gill, J., Szanton, S. L., & Page, G. G. (2005) · Biological Research For Nursing · doi:10.1177/1099800405276709 · Cited by 38 · see citing works

Diabetes and cardiovascular risk markers

Erdmann, E. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x36459 · Cited by 32 · see citing works

Oral antidiabetic agents as cardiovascular drugs

Macfarlane, D. P., Paterson, K., & Fisher, M. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00592.x · Cited by 31 · see citing works

Self-Reported Periodontitis and Incident Type 2 Diabetes among Male Workers from a 5-Year Follow-Up to MY Health Up Study

Miyawaki, A., Toyokawa, S., Inoue, K., Miyoshi, Y., & Kobayashi, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153464 · Cited by 31 · see citing works

In Addition to Insulin Resistance and Obesity, Brachial-Ankle Pulse Wave Velocity is Strongly Associated with Metabolic Syndrome in Chinese - A Population-Based Study (Taichung Community Health Study, TCHS)

Lin, W.-Y., Lai, M.-M., Li, C., Lin, C., Li, T., Chen, C., Lin, T., & Liu, C.-S. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e603 · Cited by 30 · see citing works

Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications

Kuthati, Y., Davuluri, V. N. G., & Wong, C. (2025) · Biomolecules · doi:10.3390/biom15050622 · Cited by 29 · see citing works

The Fixed Combination of Pioglitazone and Metformin Improves Biomarkers of Platelet Function and Chronic Inflammation in Type 2 Diabetes Patients: Results from the PIOfix Study

Schöndorf, T., Musholt, P. B., Hohberg, C., Forst, T. M., Lehmann, U., Fuchs, W. A., Löbig, M., Müller, J., & Pfützner, A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500233 · Cited by 29 · see citing works

The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials

Hosseini, H., Koushki, M., Khodabandehloo, H., Fathi, M., Panahi, G., Teimouri, M., Majidi, Z., & Meshkani, R. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102251 · Cited by 28 · see citing works

Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals

Almon, R. R., Wang, X., DuBois, D. C., Sukumaran, S., Ayyar, V. S., & Jusko, W. J. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s69891 · Cited by 26 · see citing works

Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study

Rogowski, O., Shapira, I., Bassat, O. K., Chundadze, T., Finn, T., Berliner, S. A., & Steinvil, A. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-35 · Cited by 26 · see citing works

Insulin Resistance and Adolescent Girls with Polycystic Ovary Syndrome

Bhattacharya, S. M., & Ghosh, M. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2009.10.004 · Cited by 24 · see citing works

Differences in Expression of Cardiovascular Risk Factors among Type 2 Diabetes Mellitus Patients of Different Age

Kalofoutis, C., Piperi, C., Zisaki, A., Singh, J., HARRIS, F., Phoenix, D. A., ALAVERAS, A., & Kalofoutis, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.001 · Cited by 23 · see citing works

The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions

Karagiannis, E., Pfützner, A., Forst, T. M., Lübben, G., Roth, W., Grabellus, M., Flannery, M., & Schöndorf, T. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0244 · Cited by 23 · see citing works

Effect of Apigenin on Neurodegenerative Diseases

Gaur, K., & Siddique, Y. H. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230406082625 · Cited by 22 · see citing works

Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.

Waheed, P., Naveed, A. K., & Farooq, F. (2009) · PubMed · Cited by 22 · see citing works

Impact of Periodontitis and Oral Dysbiosis Metabolites in the Modulation of Accelerating Ageing and Human Senescence

Amato, M., Polizzi, A., Viglianisi, G., Leonforte, F., Mascitti, M., & Isola, G. (2025) · Metabolites · doi:10.3390/metabo15010035 · Cited by 21 · see citing works

Association between retinopathy, nephropathy, and periodontitis in type 2 diabetic patients: a Meta-analysis

Wu, H., Yao, J.-Y., Qi, J.-Y., Xie, H., Sang, A., & Jiang, K. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.01.20 · Cited by 21 · see citing works

Comorbidities and Their Impact on Mortality in HCV and HCV-HIV–coinfected Persons on Dialysis

Butt, A. A., Khan, U. A., & Skanderson, M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181574d58 · Cited by 20 · see citing works

Early Effects of Hyperbaric Oxygen on Inducible Nitric Oxide Synthase Activity/Expression in Lymphocytes of Type 1 Diabetes Patients: A Prospective Pilot Study

Resanović, I., Gluvic, Z. M., Zarić, B. L., Sudar-Milovanovic, E. M., Jovanović, A., Milacic, D., Isaković, R., & Isenović, E. R. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2328505 · Cited by 19 · see citing works

Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report

Bosevski, M., Boševska, G., & Stojanovska, L. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-29 · Cited by 19 · see citing works

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study

Goldstein, B. J., Weissman, P. N., Wooddell, M. J., Waterhouse, B. R., & Cobitz, A. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115720 · Cited by 19 · see citing works

Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia

Uçkan, K., & Şahin, H. G. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13532 · Cited by 18 · see citing works

Myocardial Insulin Resistance: An Overview of Its Causes, Effects, and Potential Therapy

Toit, E. F. D., & Donner, D. G. (2012) · InTech eBooks · doi:10.5772/50619 · Cited by 17 · see citing works

C-REACTIVE PROTEIN AND CARDIOVASCULAR DISEASE IN PEOPLE WITH DIABETES

Xu, Y., & Whitmer, K. R. (2006) · AJN American Journal of Nursing · doi:10.1097/00000446-200608000-00027 · Cited by 17 · see citing works

Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus

Magge, S. N. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0274-9 · Cited by 16 · see citing works

Interplay between proteins and metabolic syndrome–A review

Miglani, N., & Bains, K. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.938259 · Cited by 16 · see citing works

Calculating Insulin Resistance in the Primary Care Setting: Why Should We Worry about Insulin Levels in Euglycemic Patients?

Appel, S. J. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2005.0052.x · Cited by 16 · see citing works

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

Zhao, L., Li, Y., Lv, Q., Wang, M., Luan, Y., Song, J., Fu, G., Ge, J., Zou, Y., & Zhang, W. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1596357 · Cited by 14 · see citing works

Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure

Macfarlane, D. P., & Fisher, M. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606050-00002 · Cited by 14 · see citing works

Insulin resistance and overweight-obese women with polycystic ovary syndrome

Bhattacharya, S. M. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903367002 · Cited by 13 · see citing works

Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies

Magodoro, I. M., Kotzé, L. A., Stek, C. J., West, A., Roux, A. L., Sobratee, N., Taliep, A., Hamada, Y., Dave, J. A., Rangaka, M. X., et al. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2508904 · Cited by 12 · see citing works

Treatment of hypertension in metabolic syndrome: Implications of recent clinical trials

Makaryus, A. N., Akhrass, P., & McFarlane, S. I. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0037-2 · Cited by 12 · see citing works

Proposal of a novel diabetogenic mechanism involving the serpin PAI‐1

Griffiths, S. L., & Grainger, D. J. (2006) · BioEssays · doi:10.1002/bies.20418 · Cited by 12 · see citing works

The effects of Elettaria cardamom supplementation on inflammatory markers and vascular function in patients with type 2 diabetes mellitus: A mechanism -based randomized clinical trial

Zahedi, S. G., Koohdani, F., Qorbani, M., Nasli‐Esfahani, E., Aghasi, M., Khoshamal, H., Keshavarz, A. A., & Sotoudeh, G. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100403 · Cited by 11 · see citing works

The Relationship between the Severity of Coronary Artery Disease and Epicardial Adipose Tissue Depends on The Left Ventricular Function

Doesch, C., Süselbeck, T., Haghi, D., Streitner, F., Schoenberg, S. O., Borggrefe, M. M., & Papavassiliu, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048330 · Cited by 10 · see citing works

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Journal, C. (2007) · Core evidence · doi:10.2147/ce.s7428 · Cited by 10 · see citing works

Synergistic effects of body fat percentage and C-reactive protein triglyceride–glucose index on cardiovascular disease risk: a Chinese cohort study

Tian, X., Qu, Z., Yang, X., Cao, Y. Y., & Zhang, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-24094-5 · Cited by 9 · see citing works

Meta-analysis of the effect of sodium-dependent glucose transporter 2 inhibitors on C-reactive protein in type 2 diabetes

Sun, W., Xing, Y., Kong, D., Zhang, Z., Ma, H., & Yang, L. (2022) · Medicine · doi:10.1097/md.0000000000030553 · Cited by 8 · see citing works

Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study

António, N., Fernandes, R., Soares, A. D. R., Soares, F., Lopes, A. P., Carvalheiro, T., Paiva, A. A., Pêgo, G. M., Providência, L. A., Gonçalves, L. M. M., et al. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1718-6 · Cited by 8 · see citing works

Circulating Prolidase Activity in Patients with Myocardial Infarction

Sultan, A., Zheng, Y., Trainor, P. J., Siow, Y., Amraotkar, A. R., Hill, B. G., & DeFilippis, A. P. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00050 · Cited by 7 · see citing works

Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.

Shahid, H., Kurdi, M. I., & Zohair, A. (2011) · PubMed · Cited by 7 · see citing works

Impact of combined non-surgical and surgical periodontal treatment in patients with type 2 diabetes mellitus-a preliminary report randomized clinical study

Bukleta, D. S., Krasniqi, S., Beretta, G., Daci, A., Nila, A., Komoni, T., Selmani, M., Elshani, B. D., & Schara, R. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-644 · Cited by 7 · see citing works

Paroi artérielle et glitazones

Valensi, P. E. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81737-8 · Cited by 7 · see citing works

High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment with Pioglitazone

Pfützner, A., Schöndorf, T., Markolf Hanefeld, E., & Forst, T. M. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400326 · Cited by 92 · see citing works

Endothelial inflammation in insulin resistance

Sjöholm, Å., & Nyström, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17912-4 · Cited by 278 · see citing works

Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes

Huerta, M. G., & Nadler, J. L. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0103-5 · Cited by 22 · see citing works

Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein

Dandona, P. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.333 · Cited by 42 · see citing works

Pre-diabetes, insulin resistance, inflammation and CVD risk

Haffner, S. M. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00122-0 · Cited by 143 · see citing works